Akers Nanotechnology is a leading global rapid diagnostic test developer and supplier, and vaccine and pharmaceutical supplier.
Akers Nanotechnology is a leader in the personal healthcare revolution of the Internet of Medical Things, and our extensive experience in the medical diagnostics industry, combined with new, cutting-edge nanotechnology platforms, positions us to accomplish just that.
Divisions
Infectious Threat Immunity Detection: Akers Nanotechnology provides the products and services required for your mission to identify infectious threats and their neutralization.
Health and Wellness: Akers Nanotechnology develops, manufactures, and distributes mobile health tests (mHealthTests™) which provide instant information on health and metabolism that enables healthy lifestyle choices based on our proprietary nanotechnology and digital application platforms. Nanotechnology for a Healthier Lifestyle
Specialty Pharmaceuticals: Akers Nanotechnology specializes in the wholesale of pharmaceutical products that are in short supply.
Core Competencies: research and development, manufacturing, commercialization, distribution, product approvals, regulatory affairs
Global footprint
Distinct record of innovation and success: Developed, patented, and commercialized numerous unique rapid diagnostic tests, including for infectious diseases, STDs, drugs of abuse, alcohol, adverse drug reactions, cholesterol, ketosis, oxidative stress, and blood type.
Seasoned, veteran management team has been working together for 40+ years.
Akers Nanotechnology is a leader in the personal healthcare revolution of the Internet of Medical Things, and our extensive experience in the medical diagnostics industry, combined with new, cutting-edge nanotechnology platforms, positions us to accomplish just that.
Global footprint
Distinct record of innovation and success: Developed, patented, and commercialized numerous unique rapid diagnostic tests, including for infectious diseases, STDs, drugs of abuse, alcohol, adverse drug reactions, cholesterol, ketosis, oxidative stress, and blood type.
Seasoned, veteran management team has been working together for 40+ years.
Akers Nanotechnology is a leader in the personal healthcare revolution of the Internet of Medical Things, and our extensive experience in the medical diagnostics industry, combined with new, cutting-edge nanotechnology platforms, positions us to accomplish just that.
FDA REG: 3016696612New Jersey Drug and Medical Device Registration: 5005855CAGE CODE: 8RFL6NAICS CODES: 541713, 423450UEI: CK8WFQTLYMV9
Raymond F. Akers, Jr., Ph.D. is the Founder and CEO of Akers Nanotechnology. He has spent the past 40 years as an innovator in rapid diagnostic test products. He has developed, patented, and commercialized numerous unique rapid diagnostic tests, including for infectious diseases, STDs, drugs of abuse, alcohol, adverse drug reactions, cholesterol, ketosis, oxidative stress, and blood type. He has also worked in the supply of rapid diagnostic tests, pharmaceuticals, and vaccines. He has taken two of his companies public in the IPO process, one on the NASDAQ and one on the London Stock Exchange's Alternative Investment Market. He holds a doctorate in Neuroscience from Northwestern University and a B.A. in Biology from Saint Joseph's University.
